Patrick has over 25 years of executive leadership experience and a proven track record in the medical device industry. He previously served as CEO of Syntach AB, and as COO and CEO with the Occlutech Group and its subsidiaries.
He’s also held C-level positions with several European and U.S. medtech and biotech start-ups. He currently serves on the board of Acorai AB and is a former board member of Scandinavian Real Heart. Patrick holds a degree in medical sciences from Harvard Medical School and conducted extensive research in molecular biology at MIT.